2-hexadecen-1-ol | 22104-83-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-hexadecen-1-ol
• 英文别名: hexadec-2-en-1-ol
• CAS: 22104-83-2
• 化学式: C₁₆H₃₂O
• 分子量: 240.429
• InChiKey: MIDSQDHRRBSMIZ-UHFFFAOYSA-N

物化性质

• 熔点：
  47.2°C (estimate)
• 沸点：
  348.15°C (rough estimate)
• 密度：
  0.8438 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  17
• 可旋转键数：
  13
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-hexadecen-1-ol 在 N-溴代丁二酰亚胺(NBS) 、 三苯基膦 作用下， 以 二氯甲烷 为溶剂， 以68%的产率得到(E)-1-bromohexadec-2-ene
  参考文献：
  名称：

  Synthesis of new ligands for targeting the S1P1 receptor

  摘要：

  Sphingosine-1-phosphate (S1P) influences various fundamental biological processes by interacting with a family of five G protein-coupled receptors (S1P(1-5)). FTY720, a sphingosine analogue, which was approved for treatment of relapsing forms of multiple sclerosis, is phosphorylated in vivo and acts as an agonist of four of the five S1P receptor subtypes. Starting from these lead structures we developed new agonists for the S1P(1) receptor. The biological activity was tested in vivo and promising ligands were fluorinated at different positions to identify candidates for positron emission tomography (PET) imaging after [F-18]-labelling. The radioligands shall enable the imaging of S1P(1) receptor expression in vivo and thus may serve as novel imaging markers of S1P-related diseases. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.01.014
• 作为产物：
  描述：

  ethyl 2-hexadecenoate 在 二异丁基氢化铝 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以95%的产率得到2-hexadecen-1-ol
  参考文献：
  名称：

  (+)-Aculeatin D 和 (+)-6-epi-Aculeatin D 的全合成

  摘要：

  螺缩酮天然产物(+)-aculeatin D和非天然(+)-6-epi-aculeatin D的立体选择性全合成已经完成。仲烯丙醇和苯基碘 (III) 双（三氟乙酸酯）（PIFA）介导的氧化螺环化的 Sharpless 动力学拆分被用作该合成的关键步骤。

  DOI：

  10.1055/s-0029-1218546

文献信息

• Total Synthesis of (+)-Aculeatin D and (+)-6-epi-Aculeatin D
  作者：J. Yadav、K. Rao、K. Ravindar、B. Reddy

  DOI：10.1055/s-0029-1218546

  日期：2010.1

  synthesis of spiroketal natural product (+)-aculeatin D and unnatural (+)-6-epi-aculeatin D has been accomplished. Sharpless kinetic resolution of secondary allylic alcohol and phenyliodine(III) bis(trifluoroacetate) (PIFA)-mediated oxidative spirocyclization were used as key steps in this synthesis.

  螺缩酮天然产物(+)-aculeatin D和非天然(+)-6-epi-aculeatin D的立体选择性全合成已经完成。仲烯丙醇和苯基碘 (III) 双（三氟乙酸酯）（PIFA）介导的氧化螺环化的 Sharpless 动力学拆分被用作该合成的关键步骤。
• Synthesis of new ligands for targeting the S1P1 receptor
  作者：Stefanie S. Schilson、Petra Keul、Rizwan S. Shaikh、Michael Schäfers、Bodo Levkau、Günter Haufe

  DOI：10.1016/j.bmc.2015.01.014

  日期：2015.3

  Sphingosine-1-phosphate (S1P) influences various fundamental biological processes by interacting with a family of five G protein-coupled receptors (S1P(1-5)). FTY720, a sphingosine analogue, which was approved for treatment of relapsing forms of multiple sclerosis, is phosphorylated in vivo and acts as an agonist of four of the five S1P receptor subtypes. Starting from these lead structures we developed new agonists for the S1P(1) receptor. The biological activity was tested in vivo and promising ligands were fluorinated at different positions to identify candidates for positron emission tomography (PET) imaging after [F-18]-labelling. The radioligands shall enable the imaging of S1P(1) receptor expression in vivo and thus may serve as novel imaging markers of S1P-related diseases. (C) 2015 Elsevier Ltd. All rights reserved.